1. Repurposing Antidiabetic Drugs for Cardiovascular Disease
   Mario Schubert et al, 2020, Frontiers in Physiology CrossRef
2. Glucagon-like peptide-1 attenuates endoplasmic reticulum stress–induced apoptosis in H9c2 cardiomyocytes during hypoxia/reoxygenation through the GLP-1R/PI3K/Akt pathways
   Gaopeng Guan et al, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
3. Omarigliptin Prevents TNF-α-Induced Cellular Senescence in Rat Aorta Vascular Smooth Muscle Cells
   Xijun Zhang et al, 2021, Chemical Research in Toxicology CrossRef
4. Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease
   Marco Sancandi et al, 2018, Frontiers in Cellular Neuroscience CrossRef
5. Dulaglutide impedes depressive-like behavior persuaded by chronic social defeat stress model in male C57BL/6 mice: Implications on GLP-1R and cAMP/PKA signaling pathway in the hippocampus
   Amal B. Darwish et al, 2023, Life Sciences CrossRef
6. Quality Matters? The Involvement of Mitochondrial Quality Control in Cardiovascular Disease
   Kai-Lieh Lin et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Stimulation of GLP-1 Receptor Inhibits Methylglyoxal-Induced Mitochondrial Dysfunctions in H9c2 Cardiomyoblasts: Potential Role of Epac/PI3K/Akt Pathway
   Narawat Nuamnaichati et al, 2020, Frontiers in Pharmacology CrossRef
8. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway
   Hong Wei et al, 2019, Journal of Diabetes Research CrossRef
9. Liraglutide ameliorates COCl2-induced oxidative stress and apoptosis in H9C2 cells via regulating cell autophagy
   Zhanqi Pang et al, 2020, Experimental and Therapeutic Medicine CrossRef
10. The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases
    Dihe Cheng et al, 2022, Drug Design, Development and Therapy CrossRef